Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumors from dividing so they
stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells from
the side effects of chemotherapy.
PURPOSE: Phase I trial to study the effectiveness of amifostine plus combination chemotherapy
in treating patients with advanced cancer.